Pacer Advisors, Inc. Roivant Sciences Ltd. Transaction History
Pacer Advisors, Inc.
- $41.8 Billion
- Q3 2024
A detailed history of Pacer Advisors, Inc. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 63,720 shares of ROIV stock, worth $764,640. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,720
Previous 55,500
14.81%
Holding current value
$764,640
Previous $586,000
25.43%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ROIV
# of Institutions
310Shares Held
507MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$791 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$790 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$649 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$500 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$424 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.45B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...